PMCB
HEALTHCAREPharmaCyte Biotech Inc
$0.77+0.04 (+5.05%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PMCB Today?
No stock-specific AI insight has been generated for PMCB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.63$1.51
$0.77
Fundamentals
Market Cap$8M
P/E Ratio—
EPS$-0.89
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin—
Debt / Equity—
Trading
Volume137K
Avg Volume (10D)—
Shares Outstanding10.7M
PMCB News
4 articles- BC-Most Active StocksYahoo Finance·Dec 4, 2025
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital DeploymentYahoo Finance·Nov 25, 2025
- PharmaCyte Biotech, Inc. Announces Closing of $7 Million FinancingYahoo Finance·Aug 20, 2025
- PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing InvestorsYahoo Finance·Aug 18, 2025
All 4 articles loaded
Price Data
Open$0.74
Previous Close$0.73
Day High$0.78
Day Low$0.72
52 Week High$1.51
52 Week Low$0.63
52-Week Range
$0.63$1.51
$0.77
Fundamentals
Market Cap$8M
P/E Ratio—
EPS$-0.89
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin—
Debt / Equity—
Trading
Volume137K
Avg Volume (10D)—
Shares Outstanding10.7M
About PharmaCyte Biotech Inc
PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United States. The company is headquartered in Laguna Hills, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—